News

Explore the complexities of chronic hand eczema, its impact on quality of life, and emerging treatment options in this insightful review.

Discover the promising results of ME3183, a novel oral treatment for plaque psoriasis, showing significant efficacy and safety in a recent study.

BioMendics initiates TAMES-02 trial for TolaSure, a groundbreaking therapy targeting the root cause of Epidermolysis Bullosa Simplex, offering new hope.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Tina Bhutani, MD, MAS, discusses innovative pediatric atopic dermatitis treatments, including ruxolitinib cream, emphasizing collaborative decision-making for effective management.

In this exclusive Q&A, Alan J. Bauman, MD, shares expert insights on innovative hair loss treatments, early intervention strategies, and the future of alopecia care.

The drug’s approval in August 2025 follows robust efficacy and safety results from the DELTA 1, 2, and 3 clinical trials.

Patients receiving BoNT-A plus topical cream reported greater satisfaction and better skin lightness than with cream alone.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore the complexities of medication sampling, balancing patient access with ethical and safety concerns in clinical practice.

Discover how Rolf-Markus Szeimies, MD, is revolutionizing at-home skin care with 5-ALA, enhancing cellular health and hydration in daily routines.

Parents advocate for children with chronic skin conditions, highlighting school challenges and the need for better support in pediatric dermatology.

This review of the latest dermatologic studies includes a review of photoprotection in patients with skin of color, the presence of inflammatory cytokines in acne patients after isotretinoin treatment, perceptions of skin-lightening products in medical students, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Shanna Miranti, MPAS, PA-C, discusses the impact of sleep loss in pediatric atopic dermatitis and the potential of emerging therapies in young patients, such as ruxolitinib cream, to improve outcomes.

Unlock exclusive insights from Elevate-Derm Summer 2025 and get expert pearls, emerging data, and clinical strategies at your fingertips.

Virginia Sybert, MD, emphasized the importance of using genetic testing judiciously in dermatologic care.

According to a new poster, patients with chronic spontaneous urticaria seek better relief options, highlighting significant impacts on quality of life and mental well-being globally.

Immutep advances eftilagimod alfa for head and neck squamous cell carcinoma, targeting patients with low PD-L1 expression and limited treatment options.

Temitayo Ogunleye, MD, guided clinicians through diverse AD cases to examine how newer agents fit into evolving treatment strategies.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

New clinical trial results reveal that intratumoral vidutolimod combined with pembrolizumab shows promise for treating advanced melanoma resistant to PD-1 therapy.

Cutaneous immune-related adverse events (cirAEs) from immune checkpoint inhibitors (ICIs) show distinct immune profiles from classic skin conditions.

Dendy Engelman, MD, FACMS, FAAD, explores the benefits of EVERESSE monopolar RF technology, emphasizing safety, comfort, and effective skin rejuvenation.

Amlitelimab shows promise in enhancing clinical outcomes and patient quality of life in atopic dermatitis, offering potential for long-term disease control.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about Johnson & Johnson's sBLA for guselkumab structural damage data, insights from LEO Pharma on the recent delgocitinib approval, the FDA's Fast Track designation for rezpegaldesleukin, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Catch up on dermatology news, highlights, and insights from the past 24 hours.